Salbutamol Completed Phase N/A Trials for Smoking / Cardiovascular Heart Disease / Chronic Obstructive Pulmonary Disease (COPD) / Bronchodilation

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00981851Interaction in Chronic Obstructive Pulmonary Disease Experiment
NCT03357341Sensor and Electronic Health Records (EHR) Integration Pilot Study
NCT01395875Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment
NCT01332461Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
NCT01331694Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)